4//SEC Filing
Nisi Rudolph 4
Accession 0001394548-17-000033
CIK 0001390478other
Filed
Oct 9, 8:00 PM ET
Accepted
Oct 10, 6:01 PM ET
Size
5.2 KB
Accession
0001394548-17-000033
Insider Transaction Report
Form 4
Nisi Rudolph
Director
Transactions
- Award
Common Stock
2017-10-10$0.38/sh+17,130$6,509→ 42,918 total
Footnotes (2)
- [F1]Effective January 1, 2017, 33% of the cash retainer payments to our Board will be paid in unrestricted shares of the Company's common stock, delivered from the 2016 Incentive Plan and priced on the first trading day of the quarter.
- [F2]Represents the closing stock price of the Company's stock on the first trading day of the quarter.
Documents
Issuer
Galena Biopharma, Inc.
CIK 0001390478
Entity typeother
Related Parties
1- filerCIK 0001297775
Filing Metadata
- Form type
- 4
- Filed
- Oct 9, 8:00 PM ET
- Accepted
- Oct 10, 6:01 PM ET
- Size
- 5.2 KB